Literature DB >> 1345005

Plasma alanine and lactate concentrations following glucose ingestion in normal and NIDDM subjects.

M Donatelli1, V Russo, M L Bucalo, A Scarpinato, A Veronelli, A Craveri.   

Abstract

Conflicting evidence has been reported on the metabolic fate of glucose following oral ingestion. We measured the metabolic pattern of gluconeogenic substrates as alanine, predominantly produced by muscle, and lactate after an oral glucose load in ten normal subjects and in eighteen non-insulin dependent diabetes mellitus (NIDDM) subjects. Neither in normal or NIDDM subjects were significant increases in plasma alanine observed, whereas a significant increase in plasma lactate was observed at 60, 90 and 120 min after a glucose load. Although a similar behaviour in plasma alanine and lactate between normal and NIDDM subjects was found, in NIDDM significantly higher levels of plasma alanine and lactate were found at each time. From these observations we conclude: 1) when glucose is ingested under post-absorptive conditions, since plasma alanine levels do not change concurrently with lactate increase, muscle tissue does not play a predominant role in glucose disposal 2) after an oral glucose load, the pattern of gluconeogenic precursors (alanine and lactate) is similar in normal and NIDDM subjects 3) the main cause of fasting and post-prandial hyperglycemia in NIDDM subjects may be due to an overproduction of alanine as well as lactate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1345005

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  2 in total

Review 1.  1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma.

Authors:  Jingjing Duan; Alfred H Merrill
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

2.  The Metabolic Responses to L-Glutamine of Livers from Rats with Diabetes Types 1 and 2.

Authors:  Jurandir Fernando Comar; Denise Silva de Oliveira; Livia Bracht; Fumie Suzuki Kemmelmeier; Rosane Marina Peralta; Adelar Bracht
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.